https://sourcingjournal.com/topics/logistics/union-pacific-norfolk-southern-merger-application-filing-teamsters-unions-enhance-competition-railroads-rail-1234794306/
Union Pacific, Norfolk Southern Seek Merger Approval; Teamsters Object
Union Pacific and Norfolk Southern filed their $85 billion merger application with the STB, but face more labor opposition from the Teamsters.
union pacific norfolksouthern
https://calgaryherald.com/commodities/energy/cnrl-tourmaline-competition-bureau-approval-natural-gas-deal/wcm/55e5685c-a3f5-4db8-a4ff-e3f13e6e3b1d
CNRL and Tourmaline seek competition bureau approval for natural gas deal: report | Calgary Herald
competition bureaunatural gas
https://www.statnews.com/2025/10/10/sarepta-gene-therapy-limb-girdle-muscular-dystrophy/
Sarepta to seek approval for gene therapy in rare muscular dystrophy | STAT
Oct 10, 2025 - Sarepta says it has what could be the first gene therapy for limb girdle muscular dystrophy. But getting through the FDA may be tough.
seek approvalgene therapyrare
https://hongkongfp.com/2024/08/21/exclusive-beijing-tells-hong-kong-based-consular-officials-to-seek-approval-before-visiting-macau-and-guangdong/
Exclusive: Beijing tells HK consular officials to seek approval for GBA visits
seek approvalexclusivebeijing
https://endpoints.news/innovent-to-seek-china-approval-of-high-dose-obesity-shot-after-phase-3-hit/
Innovent to seek China approval of high-dose obesity shot after Phase 3 hit
Nov 20, 2025 - Innovent Biologics' obesity drug Xinermei (mazdutide) at 9mg weekly dose led to 18.6% weight loss in China-based Phase 3 trial; company to seek higher dose...
obesity shotinnoventseekchina
https://www.biopharmadive.com/news/sanofi-amlitelimab-eczema-atopic-dermatitis-drug-results/810353/
Sanofi to seek approval of touted eczema drug despite mixed results | BioPharma Dive
Fresh data from multiple studies suggest the drug, which Sanofi has billed as a future blockbuster, could be cleared in the U.S. but has murky sales prospects.
seek approvaleczema drugmixed